Nirlon Limited (BOM:500307)

SpringWorks Therapeutics Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	2,182	2,056	1,579	1,108	1,274
Depreciation & Amortization	563.32	564.16	1,028	754.88	487.04
Other Amortization	183.67	189.77	195.1	151.29	144.09
Gain (Loss) on Sale of Assets	5.69	-	-	-	-
Asset Writedown	-	-	1.92	3.74	-
Change in Accounts Receivable	-8.49	-3.46	2.94	-12.64	20.41
Change in Accounts Payable	80.69	-33.18	-89.07	185.34	-16.09
Change in Other Net Operating Assets	191.27	40.58	217.11	391.8	-117
Other Operating Activities	1,601	1,434	831.37	819.73	301.76
Operating Cash Flow	4,801	4,248	3,766	3,402	2,094
Operating Cash Flow Growth	13.03%	12.78%	10.70%	62.46%	-32.64%
Acquisition of Real Estate Assets	-471.63	-549.5	-851.14	-1,610	-1,208
Sale of Real Estate Assets	8.33	-	5.91	0.97	-
Net Sale / Acq. of Real Estate Assets	-463.3	-549.5	-845.23	-1,609	-1,208
Investment in Marketable & Equity Securities	-1	1.5	-	-	-
Other Investing Activities	83.25	41.21	-59.31	15.32	10.08
Investing Cash Flow	-381.05	-506.79	-904.54	-1,594	-1,198
Long-Term Debt Issued	-	-	11,455	2,000	150
Total Debt Issued	-	-	11,455	2,000	150
Short-Term Debt Repaid	-	-	-	-	-250.09
Long-Term Debt Repaid	-	-	-11,784	-	-
Total Debt Repaid	-	-	-11,784	-	-250.09
Net Debt Issued (Repaid)	-	-	-328.66	2,000	-100.09
Common Dividends Paid	-2,343	-2,343	-2,343	-2,073	-67.59
Other Financing Activities	-976.92	-1,031	-979.98	-789.46	-828.32
Net Cash Flow	1,100	366.77	-789.95	946.26	-99.74
Cash Interest Paid	976.92	1,031	979.98	789.46	828.32
Cash Income Tax Paid	584.74	550.29	553.52	303.52	317.43
Levered Free Cash Flow	3,301	2,649	2,775	3,010	2,266
Unlevered Free Cash Flow	4,033	3,293	3,302	3,143	2,266
Change in Net Working Capital	-495.04	91.67	143.58	-839.82	-451.95

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.